New Zealand markets close in 1 hour 1 minute

AbbVie Inc. (ABBV)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
154.65+1.91 (+1.25%)
At close: 04:03PM EDT
154.50 -0.15 (-0.10%)
After hours: 07:53PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 269.59B
Enterprise value 321.84B
Trailing P/E 31.43
Forward P/E 13.95
PEG ratio (5-yr expected) 6.06
Price/sales (ttm)4.84
Price/book (mrq)20.95
Enterprise value/revenue 5.74
Enterprise value/EBITDA 15.02

Trading information

Stock price history

Beta (5Y monthly) 0.55
52-week change 39.12%
S&P500 52-week change 318.92%
52-week high 3168.11
52-week low 3130.96
50-day moving average 3148.40
200-day moving average 3149.92

Share statistics

Avg vol (3-month) 34.86M
Avg vol (10-day) 34.32M
Shares outstanding 51.77B
Implied shares outstanding 61.77B
Float 81.76B
% held by insiders 10.13%
% held by institutions 171.42%
Shares short (30 Aug 2023) 412.45M
Short ratio (30 Aug 2023) 43.02
Short % of float (30 Aug 2023) 40.71%
Short % of shares outstanding (30 Aug 2023) 40.71%
Shares short (prior month 30 Jul 2023) 411.44M

Dividends & splits

Forward annual dividend rate 45.92
Forward annual dividend yield 43.88%
Trailing annual dividend rate 35.85
Trailing annual dividend yield 33.83%
5-year average dividend yield 44.49
Payout ratio 4118.93%
Dividend date 314 Nov 2023
Ex-dividend date 411 Oct 2023
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)29 Jun 2023

Profitability

Profit margin 15.50%
Operating margin (ttm)36.50%

Management effectiveness

Return on assets (ttm)9.18%
Return on equity (ttm)63.02%

Income statement

Revenue (ttm)56.02B
Revenue per share (ttm)31.65
Quarterly revenue growth (yoy)-4.90%
Gross profit (ttm)41.53B
EBITDA 29.2B
Net income avi to common (ttm)8.63B
Diluted EPS (ttm)4.86
Quarterly earnings growth (yoy)119.00%

Balance sheet

Total cash (mrq)8.77B
Total cash per share (mrq)4.97
Total debt (mrq)61.39B
Total debt/equity (mrq)475.99%
Current ratio (mrq)0.89
Book value per share (mrq)7.29

Cash flow statement

Operating cash flow (ttm)25.54B
Levered free cash flow (ttm)23.68B